Page last updated: 2024-08-25

tricine and niacinamide

tricine has been researched along with niacinamide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biagini, S; Blower, PJ; King, R; Mather, SJ; Surfraz, MB1
Avcı, CB; Durkan, K; Gündüz, C; Ozgür, A; Susluer, SY; Yurt Lambrecht, F1
Abedi, SM; Hosseinimehr, SJ; Noaparast, Z; Varmira, K1
Abedi, SM; Ahmadpour, S; Hosseinimehr, SJ; Noaparast, Z1

Other Studies

4 other study(ies) available for tricine and niacinamide

ArticleYear
Technetium-binding in labelled HYNIC-peptide conjugates: role of coordinating amino acids.
    Journal of inorganic biochemistry, 2009, Volume: 103, Issue:7

    Topics: Animals; Cattle; Glutamic Acid; Glycine; Histidine; Hydrazines; Niacinamide; Peptides; Serum Albumin, Bovine; Spectrometry, Mass, Electrospray Ionization; Technetium

2009
In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.
    Journal of drug targeting, 2013, Volume: 21, Issue:4

    Topics: Animals; Bombesin; Cell Line, Tumor; Cysteine; Edetic Acid; Glycine; Humans; Hydrazines; Ligands; Mice; Niacinamide; Oligopeptides; Organotechnetium Compounds; Radiopharmaceuticals; Rats; Receptors, Bombesin

2013
An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers.
    Journal of drug targeting, 2014, Volume: 22, Issue:2

    Topics: Animals; Aptamers, Nucleotide; Cell Line, Tumor; Female; Glycine; Humans; Hydrazines; Indicators and Reagents; Ligands; Mice; Mice, Nude; Molecular Imaging; Niacinamide; Ovarian Neoplasms; Radiopharmaceuticals; Receptor, ErbB-2; RNA; Technetium; Tissue Distribution

2014
    Anti-cancer agents in medicinal chemistry, 2018, Volume: 18, Issue:9

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Female; Glycine; Humans; Hydrazines; MCF-7 Cells; Mice, Nude; Niacinamide; Oligopeptides; Radionuclide Imaging; Radiopharmaceuticals; Technetium

2018